Profile data is unavailable for this security.
About the company
Neuraxis, Inc. is a medical technology company focused on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults. It is engaged in advancing science with its IB-Stim therapy, based on its Percutaneous Electrical Nerve Field Stimulation (PENFS) technology, which was developed internally by the Company. The Company's first product, IB-Stim, is a PENFS system intended to be used in patients 11-18 years of age with functional abdominal pain associated with IBS. The IB-Stim is intended to be used for 120 hours per week for three consecutive weeks, and not to exceed four weeks, through application to branches of Cranial Nerves V, VII, IX and X, and the occipital nerves identified by transillumination, as an aid in the reduction of pain when combined with other therapies for IBS. Other indications in its pipeline are comprised of functional nausea in children, post-concussion syndrome in children, and cyclic vomiting syndrome in children.
- Revenue in USD (TTM)2.30m
- Net income in USD-14.39m
- Incorporated2022
- Employees19.00
- LocationNeuraxis Inc11611 N. Meridian St, Suite 330CARMEL 46032United StatesUSA
- Phone+1 (812) 689-0791
- Fax+1 (845) 818-3588
- Websitehttp://neuraxis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PAVmed Inc | 3.02m | -71.05m | 13.68m | 107.00 | -- | -- | -- | 4.53 | -9.08 | -9.08 | 0.3874 | -7.76 | 0.0588 | -- | 64.17 | 28,186.92 | -147.38 | -154.56 | -- | -1,152.82 | -126.09 | -- | -2,505.37 | -8,764.89 | 0.5301 | -8.32 | 1.82 | -- | 550.40 | -- | 25.76 | -- | 55.51 | -- |
| QT Imaging Holdings Inc | 0.00 | -4.02m | 15.52m | -- | -- | 0.7138 | -- | -- | -0.3999 | -0.3999 | 0.00 | 1.01 | 0.00 | -- | -- | -- | -12.32 | -- | -16.60 | -- | -- | -- | -- | -- | -- | -- | 0.3042 | -- | -- | -- | -45.07 | -- | -- | -- |
| Dalrada Financial Corporation | 32.16m | -21.34m | 16.57m | 0.00 | -- | 1.88 | -- | 0.5153 | -0.2388 | -0.2388 | 0.3573 | 0.091 | 1.09 | 8.86 | 3.37 | -- | -75.10 | -80.63 | -239.06 | -- | 30.11 | 39.23 | -68.78 | -63.94 | 1.24 | -21.54 | 0.3452 | -- | 54.35 | -- | -43.94 | -- | -- | -- |
| Meihua International Medical Tech Co Ltd | 97.10m | 11.63m | 16.67m | 617.00 | 1.35 | 0.1071 | 1.38 | 0.1717 | 0.4856 | 0.4856 | 4.06 | 6.11 | 0.5788 | 46.66 | 1.31 | 157,372.60 | 6.91 | 12.26 | 8.13 | 15.05 | 34.19 | 38.14 | 11.94 | 15.47 | 5.21 | -- | 0.0475 | 0.00 | -6.05 | 5.10 | 86.22 | -5.56 | -9.16 | -- |
| Orgenesis Inc | 529.00k | -45.66m | 17.73m | 146.00 | -- | -- | -- | 33.51 | -1.53 | -1.53 | 0.0174 | -0.8072 | 0.0101 | 49.69 | 0.049 | 3,623.29 | -98.12 | -- | -338.48 | -- | -660.87 | -- | -9,744.05 | -- | 0.0662 | -12.23 | -- | -- | -98.53 | -50.94 | -271.82 | -- | -17.71 | -- |
| Agape ATP Corp | 1.37m | -2.39m | 19.24m | 21.00 | -- | 5.26 | -- | 14.06 | -0.0312 | -0.0312 | 0.018 | 0.0475 | 0.394 | 9.41 | 30.79 | 65,188.57 | -68.48 | -- | -94.72 | -- | 64.84 | -- | -173.78 | -- | 4.99 | -- | 0.0204 | -- | -22.92 | -- | -24.61 | -- | -- | -- |
| Innovative Eyewear Inc | 1.39m | -7.20m | 19.84m | 11.00 | -- | 2.87 | -- | 14.26 | -0.6074 | -0.6074 | 0.1174 | 0.2948 | 0.2803 | 1.89 | 15.42 | 126,457.30 | -145.15 | -- | -168.75 | -- | -8.82 | -- | -517.88 | -- | 3.68 | -6,764.71 | 0.00 | -- | 74.67 | -- | -17.28 | -- | -- | -- |
| Ekso Bionics Holdings Inc | 17.91m | -14.24m | 20.90m | 70.00 | -- | 1.48 | -- | 1.17 | -0.9685 | -0.9685 | 1.20 | 0.7765 | 0.5423 | 1.65 | 3.38 | 255,900.00 | -43.11 | -43.63 | -57.86 | -57.67 | 50.41 | 51.93 | -79.48 | -104.24 | 2.11 | -34.63 | 0.2937 | -- | 41.57 | 10.03 | -0.7825 | -- | 3.69 | -- |
| SANUWAVE Health Inc | 22.41m | -17.26m | 21.43m | 31.00 | -- | -- | -- | 0.9563 | -0.0267 | -0.0267 | 0.0238 | -0.0417 | 1.10 | 3.60 | 7.50 | 722,838.70 | -84.54 | -136.54 | -- | -- | 71.63 | 69.13 | -77.00 | -189.60 | 0.1193 | 0.0192 | -- | -- | 21.84 | 61.61 | -150.72 | -- | -- | -- |
| Neuraxis Inc | 2.30m | -14.39m | 21.54m | 19.00 | -- | -- | -- | 9.36 | -3.71 | -3.71 | 0.4945 | -0.4829 | 1.82 | 5.81 | 10.14 | 121,135.80 | -1,154.78 | -- | -- | -- | 87.72 | -- | -633.21 | -- | 0.1016 | -13.46 | -- | -- | -8.37 | -- | -163.78 | -- | -- | -- |
| REMSleep Holdings Inc | 175.95k | -1.80m | 23.61m | 6.00 | -- | 34.87 | -- | 134.16 | -0.0012 | -0.0012 | 0.0001 | 0.0005 | 0.0848 | 1.69 | 11.20 | -- | -86.95 | -152.40 | -108.40 | -317.98 | -411.78 | -- | -1,025.38 | -2,317.52 | 1.63 | -18.54 | 0.0673 | -- | -36.48 | -- | 12.13 | -- | 28.26 | -- |
| Neuroone Medical Technologies Corp | 3.77m | -12.80m | 25.59m | 16.00 | -- | 6.35 | -- | 6.79 | -0.5877 | -0.5877 | 0.1679 | 0.1464 | 0.598 | 2.12 | 9.79 | 235,460.60 | -203.24 | -172.88 | -269.30 | -274.74 | 30.12 | -- | -339.86 | -674.97 | 2.21 | -- | 0.00 | -- | 62.66 | -- | -18.60 | -- | -- | -- |
| Femasys Inc | 1.05m | -14.90m | 26.22m | 32.00 | -- | 1.67 | -- | 24.99 | -0.8567 | -0.8567 | 0.0588 | 0.7063 | 0.0549 | 0.4939 | 8.58 | 32,785.00 | -77.93 | -- | -86.46 | -- | 65.35 | -- | -1,420.27 | -- | 8.02 | -- | 0.3057 | -- | -11.13 | -- | -25.04 | -- | -- | -- |
| SeaStar Medical Holding Corp | 0.00 | -33.67m | 28.01m | 12.00 | -- | -- | -- | -- | -1.07 | -1.07 | 0.00 | -0.0593 | 0.00 | -- | -- | 0.00 | -605.20 | -- | -- | -- | -- | -- | -- | -- | -- | -4.39 | -- | -- | -- | -- | -115.19 | -- | -- | -- |
| BioSig Technologies Inc | 27.00k | -25.25m | 28.39m | 4.00 | -- | -- | -- | 1,051.31 | -3.24 | -3.24 | 0.0033 | -0.3776 | 0.008 | -- | 1.74 | 6,750.00 | -728.65 | -269.73 | -- | -363.11 | 48.15 | -- | -91,566.66 | -24,485.73 | -- | -- | -- | -- | -93.71 | -- | -6.52 | -- | -9.58 | -- |
Data as of Jun 07 2024. Currency figures normalised to Neuraxis Inc's reporting currency: US Dollar USD
1.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Next Edge Capital Corp.as of 31 Dec 2023 | 51.84k | 0.79% |
| Stifel Nicolaus & Co., Inc. (Investment Management)as of 31 Mar 2024 | 25.71k | 0.39% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 17.75k | 0.27% |
| RBC Dominion Securities, Inc. (Investment Management)as of 31 Mar 2024 | 15.10k | 0.23% |
| Parsons Capital Management, Inc.as of 31 Mar 2024 | 13.00k | 0.20% |
| Tower Research Capital LLCas of 31 Mar 2024 | 2.81k | 0.04% |
| UBS Securities LLCas of 31 Mar 2024 | 215.00 | 0.00% |
| Manulife Investment Management Ltd.as of 31 Mar 2024 | 71.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 7.00 | 0.00% |
| JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 6.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 30 May 2024Source: FactSet Research Systems Inc.
